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The temperature d pendence of the rates of heme release from the B subunits of methemoglobin A and 
5 p mutant methemoglobins has been determined. The rates were largest for two hemoglobins with 
mutations distal to heme, previously known to be unstable. The other 3 mutants also released heme faster 
than A. These hemoglobins, with single point mutations at the cur& interface, were previously thought 
to be stable. The low reported yields of the 5 mutant proteins covaries with the relative rates of heme 
release from the met species. 
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1. INTRODUCTION 
Human hemoglobin variants exhibit a wide range 
of stabilities in the red cell [l]. Point mutations at 
positions remote from the heme ‘pocket’ or from 
the cyr,&r and cy& interfaces do not markedly 
influence the stability of the mutant protein [2]. 
However, mutations neighboring the heme result 
in anemia and increased Heinz body formation [3]. 
The mechanism(s) producing these conditions are 
not fully identified but must be mutation depen- 
dent. Mutations decrease the negative charge upon 
the ,f3 tetramer and inhibit the formation of func- 
tional c~fl dimers, producing mild anemia [4]. Al- 
ternatively the mutant ,& tetramer may undergo 
oxidation to irreversible forms of hemichromes 
which give Heinz bodies [5]. Another proposal for 
Heinz body formation and anemia is a rapid loss 
of heme from the mutant subunit followed by pre- 
cipitation of the apoprotein [3]. The latter hypo- 
thesis has only been invoked for a few mutant 
hemoglobins with mutations neighboring heme [3]. 
We have investigated the rate of heme release 
from normal metHb A and from 5 mutant methe- 
moglobins. K61n (@98 val + met) and Hammer- 
smith (,&42 phe + ser) with mutations neighboring 
the ,& heme are classic unstable hemoglobins. Saint 
MandC (@lo2 asn 4 tyr), H&e1 Dieu (899 asp + 
gly), and Malmii (p97 his * gln) are mutated at 
the crr& interface but are not considered unstable 
hemoglobins. Here we have followed the release of 
heme by monitoring spectrophotometrically the 
transfer of heme to apomyoglobin. We find that 
hemoglobins SM and HD are mildly unstable. The 
low reported yields of these proteins may be due to 
enhanced loss of the p heme. We also find the 
Arrhenius activation energies may be correlated 
with position and nature of the point mutation. 
2. MATERIALS AND METHODS 
Abbreviations: Hb, hemoglobin; Ko, Kiiln; HS, Ham- 
mersmith; SM, Saint Mandt; HD, HBtel Dieu; M6, 
Malmo 
Hemoglobins HS, Mii, SM and HD were puri- 
fied from the hemolyzates of heterozygous donors 
by chromatography on CM-52 (Whatman) using a 
pH gradient [6]. Hemoglobin Kii was isolated by 
the above method from the hemolyzate of a donor 
withfl thalassemia. Only those fractions of HS and 
Kli with near normal A&&s ratios (-0.26) were 
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used to avoid contamination with globin. The puri- 
fied proteins were concentrated by ultrafiltration 
(YM-5 membrane, Amicon) under nitrogen, dia- 
lysed against 50mM potassium phosphate, 1 mM 
EDTA (pH 7.0) and stored as beads in liquid nitro- 
gen. The spontaneous heme release was followed 
for 16 h at 409 nm using apomyoglobin as the heme 
scavenger [7]. Measurements were done in the above 
buffer, with 2-fold excess per heme basis of potas- 
sium ferricyanide, added 30 min before initiating 
the reaction by adding about 3-fold excess apo- 
myoglobin. Rate constants were estimated on an 
ABC 80 computer using a non-linear least-squares 
curve-fitting procedure with linear combination of 
two simultaneous first-order rate terms. From 30 
to 50 data points were used for each calculation. 
A Beckman DU-7@ spectrophotometer with a 
jacketed cell holder was thermostatted with an 
LKB Julabo VL water bath. Sample temperatures 
were determined by a Cormack thermistor with a 
K76P/l thermocouple. 
3. RESULTS 
The spontaneous release of heme was observed 
to be biphasic, consistent with previous results on 
exchange of heme between unlike hemoglobins [8]. 
The rapid phase was usually complete within 2-3 h 
while the slower phase exhibited a half-time of 
about 10 h. The rapid phase corresponds to the 
release of heme from the p subunits and the slower 
from the cz subunits [8]. Each phase comprised ap- 
proximately half of the total absorbance change in 
good cases; however, release of heme from the LY 
subunits at higher temperatures was accompanied 
Fig. 1. The Arrhenius plots of heme release from methe- 
moglobins A and 5 mutant methemoglobins. Activation 
energies are given in table 1. 
by a conspicuous globin precipitation. This ap- 
peared spectrophotometrically as dramatically 
increased rate of absorbance change following the 
slow absorbance change of LY heme transfer. Be- 
cause of this complication the rate constants for 
heme release from the cy subunits are thought to be 
untrustworthy. 
Fig.1 shows Arrhenius plots of heme release 
from the various methemoglobins. All mutants 
rapidly precipitated above 37”C, so activation 
energies are calculated on data from a restricted 
temperature range. Error bars have been omitted 
because the computed errors are smaller than the 
symbols. Large differences in heme release rates 
and activation energies are apparent from this 
plot. 
Table 1 
Energies of ,& heme release and preparative yields of normal and mutant hemoglobin? 
Hemoglobin 
A 
Malm(i 
H&e1 Dieu 
Saint MandC 
K61n 
Hammersmith 
Mutation bcm3. M-1 1ogA (min-‘) Ea (kJ/mol) kl (min-I)’ Yield (clro) 
_ 19.3 124+ 1 0.0064 50 
/397 his -+ gln -4.7 1 17.4 t- 0.3 0.0082 48 161 
,B99 asp ---t gly -36.5 14.5 92 + 2 0.018 43 [91 
,f3102 asn -+ tyr +30.9 43.6 + 5 0.026 38.5 [lo] 
p98 val -+ met +10.8 4 29 + 0.8 0.070 -25 [ll] 
p42 phe + ser -40.3 11.3 70 + 0.6 0.114 40 112) 
a In 50 mM phosphate, 1 mM EDTA (pH 7.0) 
bChange in van der Waals volumes; from [19] 
‘At 25°C 
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The kinetic parameters in table 1 show that all 
mutants exhibit lowered Arrhenius energies. The 
absolute rate of heme release at 25°C is higher for 
any mutant than for A. The only mutant which 
appears more stable than metHb A is metMo at 
temperatures above 25°C. The heme release from 
metSM was measured at several different concen- 
trations between 2.5 and 8.4pM heme at 21 “C, and 
the rate constant was found to be independent of 
donor concentration and dimer-tetramer equi- 
librium position. 
4. DISCUSSION 
Using apoMb as a heme ‘trap’ we have measured 
the rate of heme release from horseradish peroxi- 
dases A and C, cytochrome c peroxidase and 
IegHb [7]. However, measurement of the release 
from metHb A allows, for the first time, compari- 
son of our results with others. In a study em- 
ploying 59Fe labelled heme, authors in [8] found 
that heme exchange occurred more rapidly between 
,& and y, as we have here deduced. Their reported 
rate constants and activation energy (85 kJ/mol) 
are compatible with our rates and activation energy 
(124 kJ/mol). Complete agreement is not to be ex- 
pected since they measured exchange rates and not 
heme release. 
The high heme release rates and low activation 
energies were expected for HS and Ko. Both muta- 
tions occur in polypeptide segments forming the 
heme pocket, and any disturbance of the precise fit 
between heme and protein should alter the heme 
binding constant. The increased rates and lowered 
activation energies for the other 3 mutants were 
unexpected. While the P102 residue does contact 
the heme pyrrole II (Fischer convention [ 131) these 
mutants (HD, SM, Mo) have been previously 
thought of as being stable. We have reported low 
yields for SM [lo] and HD [9]. For HD and Mo 
neither mutation occurs at positions neighboring 
heme but at the al,& interface. One possible ex- 
planation for their instability is that mutations at 
the P99 and ,f397 positions are transmitted through 
the F helix to val 98, which contacts pyrrole II, 
disrupting packing between heme and protein and 
increasing rates of heme release. Another possi- 
bility is that any mutation at the cyi,& region in- 
creases the flexibility of the polypeptide and lowers 
the activation energy for heme release. From our 
initial study it is difficult to decide between these 
possible mechanisms. However, table 1 shows that 
activation energies are lowered more by mutations 
which increase side chain van der Waals volume. 
The importance of the study of single point 
mutant proteins has recently been highlighted by 
the finding that the normal allele H-ras-1, which 
codes for the mammalian protein ~21, becomes an 
oncogene by mutation of a single base pair [14]. 
The amino acid normally coded is glycine, and 
mutation to glutamic acid or arginine results in the 
oncogenic proteins NMU-H-ras and v-ras, respec- 
tively. The amino acid sequence of p21 is very 
hydrophobic in the neighborhood of the mutatable 
glycine, and this polypeptide sequence may reside 
in the interior of ~21. This situation is similar to 
that of hemoglobin Riverdale-Bronx (p24 gly + 
arg) [ 151. The fl24 glycine plays an important role 
in the internal structure of normal hemoglobin, 
where sliding of the E helix past this residue is de- 
manded by ‘cooperativity’. Hemoglobin Riverdale- 
Bronx is considered an unstable protein due to 
increased van der Waals volume of the p24 arginyl 
residue which destabilizes the B and E helixes. If 
p21 is a regulatory protein, or a subunit of a 
regulatory protein as suggested [ 17,181, then muta- 
tion of an internal glycyl residue to any other resi- 
due would be expected to alter the regulatory 
properties and certainly the stability of the p21 
related oncogenic proteins. It would be of interest 
to study the thermal stabilities of NMU-H-ras and 
v-ras oncogenic proteins. 
Table 1 also shows that the yields of mutant 
hemoglobins covary with heme release rates. Pre- 
vious studies used heat denaturation to assay 
hemoglobin stability, a test which combines auto- 
oxidation with heme release processes. As a check 
of the relative importance of autooxidation and 
heme release we assayed the oxidation of SM and 
A by the azide test of authors in [18] and found 
their oxidation rates to be the same (unpublished). 
Therefore, low yield of this protein is probably due 
to facile heme release. 
ACKNOWLEDGEMENTS 
This study was supported by the Faculty of 
Medicine, Umea University, and the Swedish 
Medical Research Council, grant 3X-6522. 
149 
Volume 169, number 2 FEBS LETTERS April 1984 
REFERENCES [91 
HI 
I21 
[31 
[41 
151 
El 
171 
PI 
Labie, D. and Wajcman, H. (1974) Haematologia 
8, 87-95. 
Pettigrew, D.W., Romeo, P.H., Tsapis, A., 
Thillet, J., Smith, M.L., Turner, B. W. and Ackers, 
G.K. (1982) Proc. Natl. Acad. Sci. USA 79, 
1849-1853. 
Jacob, H.S. and Winterhalter, K.H. (1970) J. Clin. 
Invest. 49, 2008-2016. 
Bunn, H.F. and McDonald, M.J. (1983) Nature 
306, 498-500. 
Rachmilewitz, E.A., Peisach, J. and Blumberg, 
W.E. (1971) J. Biol. Chem. 246, 3356-3366. 
Zak, S.J., Geller, G.R., Krivit, W., Tukey, D., 
Brineholt, B., Jones, R.T., Bunn, A.F. and 
McCormack, M. (1976) Br. J. Haematol. 33, 
101-104. 
Smith, M.L., Ohlsson, PI. and Paul, K.G. (1982) 
in: Cytochrome P-450, Biochemistry, Biophysics 
and Environmental Implications (Hietanen, E. et al. 
eds) pp. 601-606, Elsevier, Amsterdam, New York. 
Bunn, H.F. and Jandl, J.H. (1966) Proc. Natl. 
Acad. Sci. USA 56, 974-978. 
1101 
u11 
WI 
1131 
1141 
t151 
iI61 
1171 
WI 
Blouquit, Y., Braconnier, F., Galacteros, F., 
Arous, N., Soria, J., Zittoun, R. and Rosa, J. 
(1981) Hemoglobin 5, 19-31. 
Arous, N., Braconnier, F., Thillet, J., Blouquit, Y., 
Galacteros, F., Chevrier, M., Bordahandy, C. and 
Rosa, Y. (1981) FEBS Lett. 126, 114-116. 
Carrell, R.W., Lehmann, H. and Hutchinson, H.E. 
(1966) Nature 210, 915-916. 
Dacie, J.V., Shinton, N.K., Gaffney, P.J., Carrell, 
R.W. and Lehmann, H. (1967) Nature 216, 633- 
635. 
Fischer, H. and Orth, H. (1968) Die Chemie des 
Pyrroles, Johnson Reprint, New York. 
Sukumar, S., Notario, V., Martin-Zanca, D. and 
Barbacid, M. (1983) Nature 306, 658-661. 
Ranney, H.M., Jacobs, A.S., Udem, L. and 
Zalusky, R. (1968) Biochem. Biophys. Res. Com- 
mun. 33, 1004-1011. 
Gallwitz, D., Donath, C. and Sander, C. (1983) 
Nature 306, 704-707. 
De Feo-Jones, D., Scolnick, E.M., Koller, R. and 
Dhar, R. Nature 306, 707-709. 
Wallace, W.J., Houtchens, R.A., Maxwell, J.C. 
and Caughey, W.S. (1982) J. Biol. Chem. 257, 
4966-4977. 
[19] Bondi, A., (1964) J. Phys. Chem. 68, 441-451. 
150 
